Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting endothelial ERG to mitigate vascular regression in retinopathies

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2507194122Source: DataRank Database

Targeting endothelial ERG to mitigate vascular regression in retinopathies is a research paper published in Proceedings of the National Academy of Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.85)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Christopher M. Schafer ORCID,Jun Xie ORCID,Yelyzaveta Rudenko,John Knapp,Anna M. Randi ORCID

Live enrichment

PubMed:40986356 PMC:PMC12501155 OpenAlex:https://openalex.org/W4414427169

HHS | NIH

Grant: R35HL144605

HHS | NIH

Grant: P20GM139763

British Heart Foundation

Grant: RG/11/17/29256

British Heart Foundation

Grant: RG/17/4/32662

American Heart Association

Grant: 23SCEFIA1155941

American Heart Association

Grant: 24POST1196957

ARVO Foundation for Eye Research

Grant: EyeFind Research Grant

FWCI

1.85

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1073/pnas.2507194122

publisherhttps://doi.org/10.1073/pnas.2507194122

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2507194122

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40986356

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12501155

Fields of Study

Retinopathy of Prematurity StudiesRetinal Diseases and TreatmentsRetinal Development and DisordersRetinopathy of PrematurityDiabetic RetinopathyDown-RegulationProto-Oncogene Protein c-fli-1Transcriptional Regulator ERGEndothelial CellsCapillariesRetinal VesselsHumansAnimalsMiceRetinal NeovascularizationMice, Inbred C57BLMice, TransgenicDiabetes Mellitus, ExperimentalStreptozocinVisual AcuityMaleFemaleOncogene Proteins

MeSH Terms

Transcriptional Regulator ERGAnimalsCapillariesDiabetes Mellitus, ExperimentalDiabetic RetinopathyDisease Models, AnimalFemaleHumansMaleMice, Inbred C57BLMice, TransgenicRetinal VesselsRetinopathy of PrematurityStreptozocinVisual AcuityOncogene ProteinsDown-RegulationRetinal NeovascularizationEndothelial CellsMiceProto-Oncogene Protein c-fli-1

Keywords

RetinalRetinopathy of prematurityRetinaRetinopathyPathologicalHomeostasisDiabetic retinopathyNeovascularizationMicrovascular RarefactionTranscriptional Regulator Erg